Alwyn Capital
Overview
Alwyn Capital is a venture capital firm investing in groundbreaking biotechnology that eliminates the need for animals in food, fashion, and pharmaceuticals. They back scalable, sustainable innovations that drive efficiency, reduce environmental impact, and future-proof industries.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Avant Meats | Jun 2022 | Series A | Co-investor |
| NS/TX Industries | Feb 2023 | Seed | Co-investor |
| Rheom Materials | Aug 2022 | Seed | Co-investor |
| New School Foods | Feb 2023 | Seed | Co-investor |
| uFraction8 | Feb 2025 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Alwyn Capital based?
Alwyn Capital is headquartered in Florida.
When was Alwyn Capital founded?
Alwyn Capital was founded in 2018.
How many portfolio companies does Alwyn Capital have?
Alwyn Capital has 8 portfolio companies in Caplight's dataset.
What are some companies in Alwyn Capital's portfolio?
Portfolio companies visible on Caplight include Avant Meats, NS/TX Industries, Rheom Materials, New School Foods, uFraction8.
What was Alwyn Capital's most recent investment shown here?
Alwyn Capital's most recent investment in this portfolio sample was in uFraction8 in 2025.
What sectors does Alwyn Capital focus on?
Alwyn Capital focuses on Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability, Healthcare & Life Sciences, Consumer & Commerce, Frontier & Industrial Tech, Consumer & Commerce, Frontier & Industrial Tech, Frontier & Industrial Tech, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, Energy & Sustainability, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Alwyn Capital focus on?
Alwyn Capital typically invests at the Early stage.
What is Alwyn Capital's AUM?
Alwyn Capital's assets under management are estimated between $0.0 and $50.0M.